Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00768 |
| Species: | Homo sapiens |
| Position : | chr11:65200000-66000000 |
| Year: | 2024 |
| Title: | Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | T-cell acute lymphoblastic leukemia |
| PMID: | 39277592 |
| MONDO: | MONDO:0004947 |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | DND41 |
| CVCL ID: | CVCL_2022 |
| Cell Type: | T lymphoblast |
| Cell Ontology ID: | CL:0002419 |
| Experiment Type: | Chromatin interaction assay |
| High Throughput Method: | SMC1 HiChIP, H3K27ac ChIP-seq, RNA-seq |
| Low Throughput Method: | qRT-PCR, and ChIP-qPCR |
| Target gene : | KAT5 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00769 | chr11:65200000-66000000 | Blood | B cell | mantle cell lymphoma |